1930-R-MPV/high dose cytarabine overview | eviQ
![PDF] High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4416910c73a7fb4f74309dd046ab9aa41c7dd7b5/6-Figure1-1.png "PDF] High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial | Semantic Scholar")
PDF] High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial | Semantic Scholar
Frontiers | Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China
Cancers | Free Full-Text | High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity
Cancers | Free Full-Text | A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma
Retrospective analysis of 119 cases of pediatric acute promyelocytic leukemia: Comparisons of four treatment regimes
Current and emerging therapies for primary central nervous system lymphoma | Biomarker Research | Full Text
High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials | Scientific Reports
How we treat primary central nervous system lymphoma - ESMO Open
Figure 1 from Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche ...
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma | Blood Cancer Journal
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet
![Hong Kong Journal of Paediatrics [HK J Paediatr (New Series) 2022;27:249-258]](https://www.hkjpaed.org/figure/2022;27;249-258-fig1.jpg "Hong Kong Journal of Paediatrics [HK J Paediatr (New Series) 2022;27:249-258]")
Hong Kong Journal of Paediatrics [HK J Paediatr (New Series) 2022;27:249-258]
Overview of regimens and cumulative doses of ara-C and anthracyclines... | Download Scientific Diagram
High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement | Semantic Scholar
Comparison of leukemia prognostic features among arm C patients with... | Download Table
Frontiers | High-Dose Methotrexate-Induced Idiopathic Intracranial Hypertension in Infant Acute Lymphoblastic Leukemia
Frontiers | Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement | SpringerLink
Cancers | Free Full-Text | A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma
HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis | Neurological Research and Practice ...
Details of modified hyper-CVAD protocol. | Download Table
